Hamilton Lane has strengthened its Infrastructure and Real Assets Investment team with three senior hires across North America and Europe to support growth in its $111.7 billion infrastructure platform. The firm reported $49.4 billion in transaction deal flow and over $1.2 billion deployed in discretionary transactions during the first half of 2026. These hires bring extensive experience in capital formation, investment sourcing, and portfolio management, positioning Hamilton Lane to meet rising investor demand for infrastructure assets. The expansion reflects the firm's commitment to scaling its platform and delivering value to institutional and private wealth clients globally.
Hamilton Lane's global infrastructure team expansion is noted alongside Pluang's Financials-sector market snapshot as of Nov 11, 2026 19:01 WIB: Among 142 priced US Financials stocks, 77 rose and 60 fell today. WULF led with a 5.89% gain at USD 13.30 and a typical hold time of 23 days, contrasting with CLSK's similar 5.33% rise but a higher sell order activity at 87%. LMND also climbed 5.65% to USD 41.50, holding longer at 28 days.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
